Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 肿瘤学
[关键词] Targeted therapy;PARP;MET;triple-negative breast cancer;high-grade serous ovarian cancer;resistance;SHR-3162 [时效性]
